Dataset Information


MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.

ABSTRACT: PURPOSE:We conducted genome-wide miRNA-sequencing (miRNA-seq) in primary cancer tissue from patients of lung adenocarcinoma to identify markers for the presence of lymph node metastasis. EXPERIMENTAL DESIGN:Markers for lymph node metastasis identified by sequencing were validated in a separate cohort using quantitative PCR. After additional validation in the The Cancer Genome Atlas (TCGA) dataset, functional characterization studies were conducted in vitro. RESULTS:MiR-31 was upregulated in lung adenocarcinoma tissues from patients with lymph node metastases compared with those without lymph node metastases. We confirmed miR-31 to be upregulated in lymph node-positive patients in a separate patient cohort (P = 0.009, t test), and to be expressed at higher levels in adenocarcinoma tissue than in matched normal adjacent lung tissues (P < 0.0001, paired t test). MiR-31 was then validated as a marker for lymph node metastasis in an external validation cohort of 233 lung adenocarcinoma cases of the TCGA (P = 0.031, t test). In vitro functional assays showed that miR-31 increases cell migration, invasion, and proliferation in an ERK1/2 signaling-dependent manner. Notably, miR-31 was a significant predictor of survival in a multivariate cox regression model even when controlling for cancer staging. Exploratory in silico analysis showed that low expression of miR-31 is associated with excellent survival for T2N0 patients. CONCLUSIONS:We applied miRNA-seq to study microRNomes in lung adenocarcinoma tissue samples for the first time and potentially identified a miRNA predicting the presence of lymph node metastasis and survival outcomes in patients of lung adenocarcinoma.


PROVIDER: S-EPMC3823052 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5388049 | BioStudies
2019-01-01 | S-EPMC6676716 | BioStudies
2017-01-01 | S-EPMC5522058 | BioStudies
2019-01-01 | S-EPMC6862851 | BioStudies
2020-01-01 | S-EPMC7422532 | BioStudies
2016-01-01 | S-EPMC4889723 | BioStudies
1000-01-01 | S-EPMC5464826 | BioStudies
2020-01-01 | S-EPMC7403585 | BioStudies
2016-01-01 | S-EPMC4918724 | BioStudies
2020-01-01 | S-EPMC7196257 | BioStudies